Heiner Dreismann has joined the board of directors of Stratos Genomics, a Seattle-based company developing low-cost whole-genome sequencing technology. He is the former CEO of Roche Molecular Diagnostics. Dreismann holds a master's degree in biology and a PhD in microbiology and molecular biology from Westfälische Wilhelms University in Münster, Germany.
Lawrence Brody has been named chief of the Genome Technology Branch, the largest of seven branches within the Division of Intramural Research of the National Human Genome Research Institute. Brody has headed GTB's Molecular Pathogenesis Section, where he investigated genetic variants that lead to changes in metabolic pathways. He is also chief scientific officer of the Center for Inherited Disease Research, an NHGRI-affiliated facility operated by Johns Hopkins University.
Brody holds a PhD in human genetics from Hopkins and an undergraduate degree in biology from Pennsylvania State University.
Philip Awadalla has been appointed as scientific director of the CartaGene Project, which aims to study genomics factors in health and disease in more than 20,000 residents of Québec. He is a professor of pediatrics at the Université de Montréal and a researcher at the Sainte-Justine University Hospital Research Center.
Daniel Von Hoff has won the 2010 David A. Karnofsky Memorial Award from the American Society of Clinical Oncology for his work in cancer research. He will receive the award at ASCO's annual meeting in June in Chicago.
Von Hoff is the physician-in-chief at the Translational Genomics Research Institute, CSO of TGen Clinical Research Services at Scottsdale Healthcare and at US Oncology, and a clinical professor of medicine at the University of Arizona College of Medicine.